SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hypertension
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
Hypertension 2022 Aug 01;79(8)1633-1643, P Mone, F Varzideh, SS Jankauskas, A Pansini, A Lombardi, S Frullone, G SantulliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.